A groundbreaking study has revealed new possibilities for patients suffering from failed back surgery syndrome, offering hope through minimally invasive endoscopic revision procedures.
Spine tech-focused medical technology company Carlsmed has launched what it calls a state-of-the-art digital production line. The technology will allow Carlsmed to deliver its aprevo personalized ...
Theradaptive, a privately held, clinical stage biologics company developing targeted protein therapeutics for spine, orthopedics, soft tissue repair and targeted immuno-oncology, today announced the ...
BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, today announced that the Centers for Medicare & Medicaid ...